Lobbying Information
Subject Matters
- Economic Development
- Government Procurement
- Health
- Industry
- Intellectual Property
- International Trade
- Municipalities
- Regional Development
- Research and Development
- Science and Technology
- Taxation and Finance
Subject Matter Details
Grant, Contribution or Other Financial Benefit
- Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
Policies or Program
- Discussion of a possible Therapeutics Products Directorate ("TPD") workstream on complex generics regulatory pathways.
- Discussion of regulatory impediments to the launch of pediatric formulations of branded and generic products.
- Discussion on the opioids crisis and the Health minister's expectations from pharmaceutical manufacturers
- Policies aimed at facilitating generic drugs repurposing.
- Policies aimed at reinforcing pharmaceutical supply chain.
Communication Techniques
-
Written communication
-
Oral communication
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Government Institutions
-
Finance Canada (FIN)
-
Global Affairs Canada (GAC)
-
Health Canada (HC)
-
House of Commons
-
Innovation, Science and Economic Development Canada (ISED)
-
Prime Minister's Office (PMO)
-
Senate of Canada
-
Transport Canada (TC)
Government institutions added through a monthly communication report
- Natural Resources Canada (NRCan)
Client Details
Government funding
No government funding was received during the last completed financial year.
Client Contact Information
Address:
6111 Royalmount avenue, suite 100
Montreal, QC H4P 2T4
Canada
Telephone number:
514-340-9800
Web address:
https://www.pharmascience.com
Client representative
David Goodman, Chief Executive Officer
Parent Company Information
Pharmascience Inc. / Pharmascience Inc. is not a subsidiary of any other parent companies.
Coalition Members Information
Pharmascience Inc. / Pharmascience Inc. is not a coalition.
Individual, organization or corporation with a Direct Interest Beneficiary Information
The activities of Pharmascience Inc. / Pharmascience Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
Pharmascience Inc. / Pharmascience Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyist Details
Mary Anne Carter
|
No public offices held
Business address:
46 Elgin Street, Suite 200
Ottawa, ON K1P 5K6
Canada
Telephone number:
613-563-4455
Consultant Firm and Address
Firm:
Earnscliffe Strategy Group
Address:
46 Elgin Street, Suite 200
Ottawa, ON K1P 5K6
Canada
Telephone number:
613-563-4455
